Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2011
10/26/2011CN102226142A Bio-augmentation technology for fermentation process of solid-state brewing vinegar
10/26/2011CN102225325A Device for separating and/ analysing several molecular targets dissolved in a complex mixture
10/26/2011CN101712979B Method for detecting enzymatic activity of PON-1 in blood sample and application thereof
10/26/2011CN101705296B Detection method of turbot FF0922 microsatellite marker by utilizing specific primers
10/26/2011CN101701258B Primer for PCR identification of kidney bean and PCR identification method
10/26/2011CN101575648B Method for testing multi-PRC reaction of transgenic fruit
10/26/2011CN101558738B Porphyra haitanensis molecular marker-assisted selection breeding method
10/26/2011CN101550434B Porphyra yezoensis microsatellite marker screening method and use thereof
10/26/2011CN101525653B Detection method of nosiheptide preparation
10/26/2011CN101509039B Gene chip for detecting type Ia glycogenosis
10/26/2011CN101423865B Human Toll-like receptor 7 gene mononucleotide polymorphism and use thereof
10/26/2011CN101198706B Nucleic and melting analysis with saturation dyes
10/25/2011US8046175 Analytical strip reading apparatus and the analyical strip used therein
10/25/2011US8046174 System and method for identifying networks of ternary relationships in complex data systems
10/25/2011US8046172 sampling patients and/or objects and performing DNA sequencing on a first region of deoxyribonucleic acid from each bacterium sample; stored in database; tracking patients infected or objects contaminated with phylogenetically related bacteria
10/25/2011US8046171 Methods and apparatus for genetic evaluation
10/25/2011US8044259 Determining the capability of a test compound to affect solid tumor stem cells
10/25/2011US8044203 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
10/25/2011US8044195 Cross-linked glycopeptide-cephalosporin antibiotics
10/25/2011US8044193 Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide
10/25/2011US8044184 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
10/25/2011US8044182 Adiponectin and uses thereof
10/25/2011US8044176 Carbon nanotube binding peptides
10/25/2011US8043850 Fluorescent protein and gene encoding the same
10/25/2011US8043841 Nucleic acid molecules encoding alanine 2,3-aminomutases
10/25/2011US8043835 Methods for detecting and monitoring cancer using extracellular RNA
10/25/2011US8043834 Universal reagents for rolling circle amplification and methods of use
10/25/2011US8043828 Modified endoglucanase II and methods of use
10/25/2011US8043827 Single molecule-format real-time bioluminescence imaging probe
10/25/2011US8043826 Using cyclooxygenase as tool in identifying modulators of blood coagulation
10/25/2011US8043825 Serum biomarkers for Chagas disease
10/25/2011US8043823 Methods of identifying agonists and antagonists of hTASR bitter taste receptors
10/25/2011US8043819 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
10/25/2011US8043817 Method of determining efficiency of ovum collection in bovine
10/25/2011US8043816 Compositions and methods for temperature-dependent nucleic acid synthesis
10/25/2011US8043815 Methods for analysis of PDEF and survivin as interconnected cancer biomarkers and targets for personalized medicine
10/25/2011US8043814 Thermoelectric method of sequencing nucleic acids
10/25/2011US8043813 Method of detecting H5 or H7 avian influenza virus
10/25/2011US8043812 Method of detecting Streptococcus pneumoniae, primer set for the detection and kit for the detection
10/25/2011US8043811 Purification method and kits
10/25/2011US8043810 Analyte detection using autocatalytic chain reactions
10/25/2011US8043809 Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs
10/25/2011US8043808 Using methylation state cpg-islands as diagnostic and/or prognostic tool in detection of cancer, diabetes and/or alzheimer's diseases
10/25/2011US8043807 Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
10/25/2011US8043806 Method of diagnosing an RTK-hyperfunction induced disorder
10/25/2011US8043805 Detection of high grade dysplasia in cervical cells
10/25/2011US8043804 DBC1, a novel native inhibitor of anti-aging protein SIRT1
10/25/2011US8043803 Slitrks as markers for stem and progenitor cells and methods of use thereof
10/25/2011US8043802 Fluorescence based biosensor
10/25/2011US8043801 Method of screening for agents to treat heart failure
10/25/2011US8043559 System for temperature control within an automatic biological analyzer
10/25/2011CA2448329C Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/25/2011CA2442349C Identifying and characterizing genes
10/25/2011CA2437866C Novel clock gene bmal2
10/25/2011CA2435551C Families of non-cross-hybridizing polynucleotides for use as tags and tag complements, manufacture and use thereof
10/25/2011CA2415923C Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
10/25/2011CA2395499C Chlamydia antigens and corresponding dna fragments and uses thereof
10/25/2011CA2366277C Grb7 family proteins and the insulin receptor for screening new medications
10/25/2011CA2239815C A method and apparatus for holding cells
10/21/2011WO2010120518A2 Sperm cell separation methods and compositions containing sperm cell targeting ligands for use therein
10/21/2011CA2793945A1 Sperm cell separation methods and compositions containing sperm cell targeting ligands for use therein
10/20/2011WO2011130691A2 Gna11 and gnaq exon 4 mutations in melanoma
10/20/2011WO2011130636A2 Methods and compositions for identifying mutations in cancer related genes
10/20/2011WO2011130635A2 Primers, probes, methods and kits for the detection of eml4-alk variants
10/20/2011WO2011130595A2 Sirtuin activators and activation assays
10/20/2011WO2011130584A2 Methods for measuring enzyme activity useful in determining cell viability in non-purified samples
10/20/2011WO2011130544A2 Monitoring a dynamic system by liquid chromatography-mass spectrometry
10/20/2011WO2011130495A1 Methods of evaluating response to cancer therapy
10/20/2011WO2011130435A1 Biomarkers based on a multi-cancer invasion-associated mechanism
10/20/2011WO2011130332A1 Glycan arrays for high throughput screening of viruses
10/20/2011WO2011130331A2 Detection and quantification of cellular stress response resolution pathway expression and functionality and the effects of agents or conditions thereupon
10/20/2011WO2011130312A1 Synthetic hybrid nanopore devices and uses thereof
10/20/2011WO2011130273A2 Optimized oligonucleotides and methods of using same for the screening, detection, isolation, quantitation, monitoring and sequencing of prostate cancer associated viruses and host biomarkers
10/20/2011WO2011130265A2 Kras primers and probes
10/20/2011WO2011130184A2 SYSTEMS AND METHODS FOR MODEL-BASED qPCR
10/20/2011WO2011130119A2 Methods of producing high titer, high purity virus stocks and methods of use thereof
10/20/2011WO2011129844A1 Prognostic markers and methods for prostate cancer
10/20/2011WO2011129710A1 Microarrays
10/20/2011WO2011129494A1 Nucleolin specific aptamer and use thereof
10/20/2011WO2011129371A1 GENE GROUP CAPABLE OF ENHANCING ANTI-TUMOR EFFECT OF 5-FU ALONE OR IFN-α/5-FU COMBINATION
10/20/2011WO2011129348A1 Composition for treatment of cancer which is produced from cancer-tissue-derived cell mass or cancer cell aggregate, and process for production of immunotherapeutic agent and method for evaluation of efficacy of immunotherapy both using the composition
10/20/2011WO2011129091A1 Primer set for pcr, reaction liquid for pcr, and method for detecting food poisoning bacteria
10/20/2011WO2011128900A2 Early detection and staging of colorectal cancer using a panel of micro rnas
10/20/2011WO2011128886A1 A micro-rna for cancer diagnosis, prognosis and therapy
10/20/2011WO2011128820A2 Methods for the analysis of breast cancer disorders
10/20/2011WO2011128646A2 Genetic markers for paget's disease
10/20/2011WO2011128377A1 Method for the selection of a long-term producing cell
10/20/2011WO2011128280A1 Prediction of early virological response in hcv treatment
10/20/2011WO2011128278A1 Single nucleotide polymorphisms that predict hcv treatment outcomes
10/20/2011WO2011128096A1 Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
10/20/2011WO2011127561A1 Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation
10/20/2011WO2011127527A1 Method and system for detecting regulatory single nucleotide polymorphisms
10/20/2011WO2011106549A3 Methods for determining gene-nutrient interactions
10/20/2011WO2011094759A3 Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignancies
10/20/2011WO2011084882A3 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
10/20/2011WO2011084783A3 Novel pneumovirus compositions and methods for using the same
10/20/2011WO2011079839A3 Soiling
10/20/2011WO2011079017A3 Differentiation of human embryonic stem cells
10/20/2011WO2011072007A3 Methods and compositions for detection and identification of organophosphorus nerve agents, pesticides and other toxins
10/20/2011WO2011071923A3 Multi-sample indexing for multiplex genotyping